CLRX on NASDAQ
Advanced biomedical technology company based in San Francisco, founded in 20081
CollabRx, Inc. was a company that offered cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolved around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available.2 Its shares trade on NASDAQ under the symbol CLRX.1 Wikipedia text CC BY-SA 4.0
Price unavailable
Last updated Oct 21, 2026.
See how the biggest companies compare on our leaderboards
CollabRx, Inc. was a company that offered cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolved around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available. The knowledgebases that inform the models were updated by a large network of advisors from academic and medical institutions.2
CollabRx was founded in 2008 by computer scientist Jeff Shrager, Silicon Valley internet pioneer Jay Martin Tenenbaum, and mathematician Raphael Lehrer.
In July 2012, Tegal Corporation acquired CollabRx.
In October 2015, CollabRx was merged with Medytox solutions.
From Wikipedia’s article on CollabRx, shared under CC BY-SA 4.0.3
The numbers on this page point here. Each one links to the record it came from.
